Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Alleged Actos Injuries Prompt Lawsuit

Filed February 13th, 2013 admin

A Pennsylvania man has filed a lawsuit alleging that Actos caused him to develop bladder cancer.

The lawsuit was filed by the national law firm, Parker Waichman LLP, in the U.S. District Court for the Western District of Louisiana, Lafayette Division, where it is just one of many cases pending in the Actos multidistrict litigation (MDL). Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company have been named as defendants.

The man began taking Actos in August 2009 and developed bladder cancer in March 2011, allegedly due to using Acts. The lawsuit alleges that Takeda knew Actos could cause bladder cancer but did not warn the public. Instead, the suit alleges, the defendants made misrepresentations and omissions in order to hide the risks of taking Actos. The lawsuit claims that there are several safer alternatives for treating Type 2 diabetes, and that the man would not have taken Actos if he were fully informed of the risks. The man is suing for severe mental and physical pain and suffering, permanent injuries, emotional distress and economic loss due to medical expenses and living-related expenses due to a new lifestyle.

The U.S. Food and Drug Administration (FDA) ordered a change to the Actos label after receiving data from an ongoing 10-year study conducted by Kaiser Permanente. The data revealed that using Actos for more than one year may significantly increase the risk of developing bladder cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!